We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$705M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Corvus Pharmaceuticals
CRVS
$1.17B
| $1.78M | ﹤0.01% |
125,000
| – | – |
|
|
WCIC
1827
DELISTED
WCI Communities, Inc.
WCIC
| $1.78M | ﹤0.01% |
105,382
+2,431
| +2% | +$41.6K |
|
|
PGTI
1828
DELISTED
PGT, Inc.
PGTI
| $1.77M | ﹤0.01% |
171,805
-1,641
| -0.9% | -$16.9K |
|
1829
TransDigm Group
TDG
$71.3B
| $1.77M | ﹤0.01% |
6,705
-140
| -2% | -$34.2K |
|
1830
Modine Manufacturing
MOD
$10.7B
| $1.76M | ﹤0.01% |
200,331
+121,931
| +156% | +$1.26M |
|
1831
CALL
AutoZone
AZO
$49.4B
| $1.75M | ﹤0.01% |
2,200
+1,500
| +214% | +$1.16M |
|
1832
CALL
Progressive
PGR
$123B
| $1.75M | ﹤0.01% |
52,100
+23,100
| +80% | +$764K |
|
1833
General Mills
GIS
$19.3B
| $1.74M | ﹤0.01% |
24,454
-1,005
| -4% | -$64K |
|
|
HTBK
1834
DELISTED
Heritage Commerce
HTBK
| $1.74M | ﹤0.01% |
165,462
-18,418
| -10% | -$192K |
|
1835
Groupon
GRPN
$1.04B
| $1.73M | ﹤0.01% |
26,681
| – | – |
|
|
CTLP
1836
DELISTED
Cantaloupe
CTLP
| $1.73M | ﹤0.01% |
405,953
-39,308
| -9% | -$168K |
|
|
TVRD
1837
Tvardi Therapeutics
TVRD
$19M
| $1.73M | ﹤0.01% |
10,007
-2,260
| -18% | -$492K |
|
1838
CALL
NVIDIA
NVDA
$5.13T
| $1.73M | ﹤0.01% |
1,472,000
+1,124,000
| +323% | +$1.16M |
|
|
TARO
1839
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.73M | ﹤0.01% |
11,873
+9,473
| +395% | +$1.34M |
|
|
FNFG
1840
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $1.73M | ﹤0.01% |
177,517
+30,457
| +21% | +$314K |
|
1841
CALL
Xcel Energy
XEL
$48.6B
| $1.72M | ﹤0.01% |
38,400
-10,000
| -21% | -$414K |
|
|
DVAX
1842
DELISTED
Dynavax Technologies
DVAX
| $1.71M | ﹤0.01% |
117,492
+13,626
| +13% | +$233K |
|
1843
Omnicom Group
OMC
$22.4B
| $1.71M | ﹤0.01% |
21,012
+18,434
| +715% | +$1.53M |
|
|
ELNK
1844
DELISTED
EarthLink Holdings Corp.
ELNK
| $1.71M | ﹤0.01% |
267,484
+114,272
| +75% | +$700K |
|
1845
CBIZ
CBZ
$2.99B
| $1.71M | ﹤0.01% |
164,305
-28,912
| -15% | -$298K |
|
1846
CALL
Boston Scientific
BSX
$71.1B
| $1.71M | ﹤0.01% |
73,100
+54,000
| +283% | +$1.17M |
|
1847
Globus Medical
GMED
$11.1B
| $1.68M | ﹤0.01% |
70,445
-464,807
| -87% | -$11.1M |
|
1848
Molson Coors Class B
TAP
$7.93B
| $1.67M | ﹤0.01% |
16,547
+2,870
| +21% | +$282K |
|
1849
CALL
Prologis
PLD
$130B
| $1.67M | ﹤0.01% |
34,100
-5,900
| -15% | -$277K |
|
1850
CALL
S&P Global
SPGI
$122B
| $1.66M | ﹤0.01% |
+15,500
| New | +$1.66M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.